Caterina Sposetti, MD

Honored to be awarded with the Bonadonna Fellowship, to support my research on metabolism in breast cancer at DFCI/HMS. Very grateful to @FondazioneBona1, @AIRC_it, #PradaGroup & my mentors Dr. Vernieri, Prof. De Braud (@IstTumori) and Dr. Ligibel (@DFCI_BreastOnc @harvardmed)!

Thanks so much to @ladolcevitamag_, a magazine of my dear and wonderful region #Abruzzo 🇮🇹, for the interest in my achievement!

🔥More than 4⃣ in🔟medical #oncologists meet the criteria for #burnout 🔥 💬 “Burnout puts the individual at higher risk for divorce, substance abuse, depression and suicide,” Dr. Jennifer A. Ligibel @DFCI_BreastOnc told @GoHealio #ASCO25 👇 healio.com/news/hematolog…

Amid Oncologist Faculty Departures, Data Offer Insights on Burnout - Jennifer A. Ligibel, MD: Medical oncologists see a tremendous amount of loss. But there's also a very strong connection with the patient, and there ... - ift.tt/Dqgyj95

Tangible goal to implement for everyone including cancer patients. 5000 steps a day looks quite good for all cause mortality.

Dr. Jennifer Ligibel closed out Day 1 of the #HarvardBreastCancerCourse with a special lecture on lifestyle, diet and exercise in #BreastCancer patients, touching on hot topics such as the #ChallengeTrial, #GLP1s and #weightloss.

Regular exercise isn’t just great for fitness. It can also reduce cancer risk by managing weight, improving immunity, and lowering inflammation.

Here's the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (July 4th-July 11th, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

@DFCI_BreastOnc and @DanaFarberZakim are leading a Randomized Phase III Clinical Trial of #Yoga for Chemotherapy-Induced Peripheral Neuropathy (#CIPN) Treatment. For email: [email protected] or visit rally.massgeneralbrigham.org/study/yctstudy Study PI: @tingbao2011 @MassGenBrigham…

It's easy to recommend exercise for better overall health but I had a truly remarkable day in clinic empowering patients with colon cancer to follow an evidence-based, post-op fitness program that offers a survival benefit on par with some chemo drugs Bodies in motion, indeed!

New 📰on racial and ethnic variation in body composition and prognosis of nonmetastatic #BreastCancer. "We found that even at the same body size measured via #BMI there are racial and ethnic differences in #adiposity and muscularity that could partially explain #disparities in…

#ASCO25 Abstract 9005: Despite similar #Burnout rates across specialties, hematologists/oncologists report higher professional fulfillment—driven by patient gratitude & team alignment. Insights from Dr Jennifer Ligibel: bit.ly/4knIbIi @DFCI_BreastOnc @JCO_ASCO

Cancer vaccines will be a big part of the future of immunotherapy. A new, super review @TheLancet thelancet.com/journals/lance…

“If a drug showed it could improve survival rates by 7%, it would likely get federal approval” Comments on the CHALLENGE trial, showing benefit of adj exercise in pts with colon cancer

This is the inflammatory subtype of depression. 🧵1/10

Our partnership with @DGlaucomflecken continues as he summarizes recent research into male-partner treatment to prevent recurrence of bacterial vaginosis. Access the article for free: nej.md/DrG17

Just a reminder that it’s okay to protect your time. It’s okay to set boundaries. It’s okay to say no. In fact, this helps us prioritize our health, our creativity, and our relationships, and our ability to do this work.

We’re proud to be recognized by @Newsweek as one of America’s Greatest Workplaces in Healthcare 2025! Thank you to our incredible staff who makes Dana-Farber such a special place to work. View the full list here: bit.ly/3SH7cC6

After ASCO, so much to discuss about breast cancer! Which agents, when, for how long, in whom? Get all the answers at our renowned 2-day breast program with outstanding faculty from @DanaFarber & @MGHCancerCenter @harvardmed Inperson and virtual options cmecatalog.hms.harvard.edu/breast-cancer-…